Comment on the FDA PRO Guidance from QualityMetric Inc and the Health Assessment Lab 1 Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D
Type: article
Authors: Gene Wallenstein, Milena Anatchkova, John E. Ware
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7096557888
